Parkwalk has returned to back three-dimensional imaging developer Fuel3D as the Oxford spinout continues work on a scanner than can accurately detail sub-cutaneous tumours.

Fuel3D, a UK-based 3D imaging technology developer spun out from University of Oxford, has received an undisclosed amount of funding from fund manager Parkwalk Advisors’ Opportunities EIS Fund.
Parkwalk Advisors is owned by commercialisation firm IP Group.
Founded in 2013, Fuel3D has created scanning technology that can accurately capture images of a 3D object by using stereo photometrics, a computer vision technique used to estimate an object’s surface normals by assessing images taken under different lighting conditions.